In addition, while this study focuses on the specific impact of toxic tau oligomers in tauopathy development in healthy iPSC-derived cells, the AstTau model is well-suited to be used with a range of iPSC backgrounds including those with mutations that have been shown to contribute to disease progression. Here, MAPT is linked to tauopathy.